Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.

Montealegre S, van Endert PM.

Front Immunol. 2019 Jan 7;9:3098. doi: 10.3389/fimmu.2018.03098. eCollection 2018. Review.

2.

Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.

Ghez D, Lepelletier Y, Lambert S, Fourneau JM, Blot V, Janvier S, Arnulf B, van Endert PM, Heveker N, Pique C, Hermine O.

J Virol. 2006 Jul;80(14):6844-54.

3.

Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines.

Fruci D, Ferracuti S, Limongi MZ, Cunsolo V, Giorda E, Fraioli R, Sibilio L, Carroll O, Hattori A, van Endert PM, Giacomini P.

J Immunol. 2006 Apr 15;176(8):4869-79.

4.

A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein.

Samino Y, López D, Guil S, Saveanu L, van Endert PM, Del Val M.

J Biol Chem. 2006 Mar 10;281(10):6358-65. Epub 2006 Jan 6.

5.

Identification of naturally processed HLA-A2--restricted proinsulin epitopes by reverse immunology.

Hassainya Y, Garcia-Pons F, Kratzer R, Lindo V, Greer F, Lemonnier FA, Niedermann G, van Endert PM.

Diabetes. 2005 Jul;54(7):2053-9.

6.

Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.

Saveanu L, Carroll O, Lindo V, Del Val M, Lopez D, Lepelletier Y, Greer F, Schomburg L, Fruci D, Niedermann G, van Endert PM.

Nat Immunol. 2005 Jul;6(7):689-97. Epub 2005 May 22.

PMID:
15908954
7.

CD4+ T cell proliferation in response to GAD and proinsulin in healthy, pre-diabetic, and diabetic donors.

Mannering SI, Morris JS, Stone NL, Jensen KP, VAN Endert PM, Harrison LC.

Ann N Y Acad Sci. 2004 Dec;1037:16-21.

PMID:
15699488
8.

Calreticulin promotes folding of functional human leukocyte antigen class I molecules in vitro.

Culina S, Lauvau G, Gubler B, van Endert PM.

J Biol Chem. 2004 Dec 24;279(52):54210-5. Epub 2004 Oct 19.

9.

Detection of low-frequency human antigen-specific CD4(+) T cells using MHC class II multimer bead sorting and immunoscope analysis.

Lemaître F, Viguier M, Cho MS, Fourneau JM, Maillère B, Kourilsky P, Van Endert PM, Ferradini L.

Eur J Immunol. 2004 Oct;34(10):2941-9.

10.

The elusive case for a role of mimicry in autoimmune diseases.

Fourneau JM, Bach JM, van Endert PM, Bach JF.

Mol Immunol. 2004 Feb;40(14-15):1095-102. Review.

PMID:
15036914
11.

A chaperone-assisted high yield system for the production of HLA-DR4 tetramers in insect cells.

Fourneau JM, Cohen H, van Endert PM.

J Immunol Methods. 2004 Feb 15;285(2):253-64.

PMID:
14980439
12.

Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient.

Banga JP, Moore JK, Duhindan N, Madec AM, van Endert PM, Orgiazzi J, Endl J.

Clin Exp Immunol. 2004 Jan;135(1):74-84.

13.

A sensitive method for detecting proliferation of rare autoantigen-specific human T cells.

Mannering SI, Morris JS, Jensen KP, Purcell AW, Honeyman MC, van Endert PM, Harrison LC.

J Immunol Methods. 2003 Dec;283(1-2):173-83.

PMID:
14659909
14.

Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors.

Peters B, Bulik S, Tampe R, Van Endert PM, Holzhütter HG.

J Immunol. 2003 Aug 15;171(4):1741-9.

15.

Differential proteasomal processing of hydrophobic and hydrophilic protein regions: contribution to cytotoxic T lymphocyte epitope clustering in HIV-1-Nef.

Lucchiari-Hartz M, Lindo V, Hitziger N, Gaedicke S, Saveanu L, van Endert PM, Greer F, Eichmann K, Niedermann G.

Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7755-60. Epub 2003 Jun 16.

16.

Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport.

Fruci D, Lauvau G, Saveanu L, Amicosante M, Butler RH, Polack A, Ginhoux F, Lemonnier F, Firat H, van Endert PM.

J Immunol. 2003 Mar 15;170(6):2977-84.

17.

Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.

Cohen WM, Bianco A, Connan F, Camoin L, Dalod M, Lauvau G, Ferriès E, Culmann-Penciolelli B, van Endert PM, Briand JP, Choppin J, Guillet JG.

J Virol. 2002 Oct;76(20):10219-25.

18.

Powering the peptide pump: TAP crosstalk with energetic nucleotides.

van Endert PM, Saveanu L, Hewitt EW, Lehner P.

Trends Biochem Sci. 2002 Sep;27(9):454-61.

PMID:
12217520
19.

Designing peptide vaccines for cellular cross-presentation.

van Endert PM.

Biologicals. 2001 Sep-Dec;29(3-4):285-8.

PMID:
11851329
20.
21.
22.
23.

Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.

De Oliveira DB, Harfouch-Hammoud E, Otto H, Papandreou NA, Stern LJ, Cohen H, Boehm BO, Bach J, Caillat-Zucman S, Walk T, Jung G, Eliopoulos E, Papadopoulos GK, van Endert PM.

Mol Immunol. 2000 Oct;37(14):813-25.

PMID:
11257303
24.

Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.

Lucchiari-Hartz M, van Endert PM, Lauvau G, Maier R, Meyerhans A, Mann D, Eichmann K, Niedermann G.

J Exp Med. 2000 Jan 17;191(2):239-52.

25.

Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells.

Lauvau G, Kakimi K, Niedermann G, Ostankovitch M, Yotnda P, Firat H, Chisari FV, van Endert PM.

J Exp Med. 1999 Nov 1;190(9):1227-40.

26.

Tapasin enhances assembly of transporters associated with antigen processing-dependent and -independent peptides with HLA-A2 and HLA-B27 expressed in insect cells.

Lauvau G, Gubler B, Cohen H, Daniel S, Caillat-Zucman S, van Endert PM.

J Biol Chem. 1999 Oct 29;274(44):31349-58.

27.

Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.

Harfouch-Hammoud E, Walk T, Otto H, Jung G, Bach JF, van Endert PM, Caillat-Zucman S.

Diabetes. 1999 Oct;48(10):1937-47.

PMID:
10512357
28.

Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.

Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA.

J Autoimmun. 1999 Sep;13(2):267-82.

PMID:
10479395
30.

Genes regulating MHC class I processing of antigen.

van Endert PM.

Curr Opin Immunol. 1999 Feb;11(1):82-8. Review.

PMID:
10047538
31.

Substrate selection by transporters associated with antigen processing occurs during peptide binding to TAP.

Gubler B, Daniel S, Armandola EA, Hammer J, Caillat-Zucman S, van Endert PM.

Mol Immunol. 1998 Jun;35(8):427-33.

PMID:
9798647
32.

Are there unique autoantigens triggering autoimmune diseases?

Bach JF, Koutouzov S, van Endert PM.

Immunol Rev. 1998 Aug;164:139-55. Review.

PMID:
9795772
33.

The DAM gene family encodes a new group of tumor-specific antigens recognized by human leukocyte antigen A2-restricted cytotoxic T lymphocytes.

Fleischhauer K, Gattinoni L, Dalerba P, Lauvau G, Zanaria E, Dabovic B, van Endert PM, Bordignon C, Traversari C.

Cancer Res. 1998 Jul 15;58(14):2969-72.

34.

Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules.

Daniel S, Brusic V, Caillat-Zucman S, Petrovsky N, Harrison L, Riganelli D, Sinigaglia F, Gallazzi F, Hammer J, van Endert PM.

J Immunol. 1998 Jul 15;161(2):617-24.

35.

Identification of mimicry peptides based on sequential motifs of epitopes derived from 65-kDa glutamic acid decarboxylase.

Bach JM, Otto H, Jung G, Cohen H, Boitard C, Bach JF, van Endert PM.

Eur J Immunol. 1998 Jun;28(6):1902-10.

36.

Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells.

White CA, Thomson SA, Cooper L, van Endert PM, Tampe R, Coupar B, Qiu L, Parsons PG, Moss DJ, Khanna R.

Int J Cancer. 1998 Feb 9;75(4):590-5.

37.

Absence of functional relevance of human transporter associated with antigen processing polymorphism for peptide selection.

Daniel S, Caillat-Zucman S, Hammer J, Bach JF, van Endert PM.

J Immunol. 1997 Sep 1;159(5):2350-7.

PMID:
9278325
38.

High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.

Bach JM, Otto H, Nepom GT, Jung G, Cohen H, Timsit J, Boitard C, van Endert PM.

J Autoimmun. 1997 Aug;10(4):375-86.

PMID:
9237801
39.
40.

The peptide-binding motif for the human transporter associated with antigen processing.

van Endert PM, Riganelli D, Greco G, Fleischhauer K, Sidney J, Sette A, Bach JF.

J Exp Med. 1995 Dec 1;182(6):1883-95.

41.

A viral inhibitor of peptide transporters for antigen presentation.

Früh K, Ahn K, Djaballah H, Sempé P, van Endert PM, Tampé R, Peterson PA, Yang Y.

Nature. 1995 Jun 1;375(6530):415-8.

PMID:
7760936
42.

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes.

Panina-Bordignon P, Lang R, van Endert PM, Benazzi E, Felix AM, Pastore RM, Spinas GA, Sinigaglia F.

J Exp Med. 1995 May 1;181(5):1923-7.

43.
44.

Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells.

Meyer TH, van Endert PM, Uebel S, Ehring B, Tampé R.

FEBS Lett. 1994 Sep 12;351(3):443-7.

45.

A sequential model for peptide binding and transport by the transporters associated with antigen processing.

van Endert PM, Tampé R, Meyer TH, Tisch R, Bach JF, McDevitt HO.

Immunity. 1994 Sep;1(6):491-500.

PMID:
7895159
46.

Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM.

van Endert PM, Liblau RS, Patel SD, Fugger L, Lopez T, Pociot F, Nerup J, McDevitt HO.

Diabetes. 1994 Jan;43(1):110-7.

PMID:
7903260
47.

Antigen processing gene polymorphisms in HLA-DR2 multiple sclerosis.

Liblau R, van Endert PM, Sandberg-Wollheim M, Patel SD, Lopez MT, Land S, Fugger L, McDevitt HO.

Neurology. 1993 Jun;43(6):1192-7.

PMID:
7909590
48.

Genomic polymorphism, recombination, and linkage disequilibrium in human major histocompatibility complex-encoded antigen-processing genes.

van Endert PM, Lopez MT, Patel SD, Monaco JJ, McDevitt HO.

Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11594-7.

49.
50.

Monoclonal antibodies to idiotype inhibit in vitro growth of human B-cell lymphomas.

van Endert PM, Heilig B, Hämmerling GJ, Moldenhauer G.

Blood. 1992 Jan 1;79(1):129-37.

PMID:
1728304

Supplemental Content

Loading ...
Support Center